$CTGO
Contango ORE, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024126724 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.795M $3.200M
YoY Change 0.9% 47.04%
% of Gross Profit
Research & Development $3.138M $862.0K
YoY Change 159.32% -63.26%
% of Gross Profit
Depreciation & Amortization $34.26K $22.62K
YoY Change 31.78% -33.9%
% of Gross Profit
Operating Expenses $2.795M $4.088M
YoY Change -30.13% -10.28%
Operating Profit $22.74M
YoY Change -336.5%
Interest Expense -$4.148M -$22.88M
YoY Change -54.66% 134.65%
% of Operating Profit -18.24%
Other Income/Expense, Net -$31.73M $140.1K
YoY Change 247.05% -101.44%
Pretax Income -$8.994M -$27.62M
YoY Change -31.61% 93.01%
Income Tax $718.8K
% Of Pretax Income
Net Earnings -$9.712M -$27.62M
YoY Change -26.14% 93.01%
Net Earnings / Revenue
Basic Earnings Per Share -$0.81
Diluted Earnings Per Share -$0.81 -$2.79
COMMON SHARES
Basic Shares Outstanding 12.23M 12.15M 9.400M
Diluted Shares Outstanding 11.97M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.17M $15.50M
YoY Change 95.38% 76.89%
Cash & Equivalents $36.17M $15.50M
Short-Term Investments
Other Short-Term Assets $1.319M $1.345M
YoY Change -16.5% 28.43%
Inventory
Prepaid Expenses $1.084M $1.113M
Receivables
Other Receivables
Total Short-Term Assets $37.48M $16.85M
YoY Change 86.65% 71.72%
LONG-TERM ASSETS
Property, Plant & Equipment $52.49M $13.33M
YoY Change 293.07% -0.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $67.54M $28.06M
YoY Change 215.32%
Other Assets $120.8M $350.6K
YoY Change 247.53% -97.39%
Total Long-Term Assets $120.8M $41.74M
YoY Change 247.53% 210.42%
TOTAL ASSETS
Total Short-Term Assets $37.48M $16.85M
Total Long-Term Assets $120.8M $41.74M
Total Assets $158.3M $58.59M
YoY Change 188.63% 151.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.379M $250.7K
YoY Change 11.71% 66.41%
Accrued Expenses $12.23M $2.241M
YoY Change 1302.72% 78.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $34.90M $7.900M
YoY Change 1645.0%
Total Short-Term Liabilities $80.48M $13.07M
YoY Change 1509.25% 830.02%
LONG-TERM LIABILITIES
Long-Term Debt $38.96M $36.78M
YoY Change 18.59% 90.07%
Other Long-Term Liabilities $46.78M $23.28M
YoY Change 684.85% 609.66%
Total Long-Term Liabilities $88.07M $60.06M
YoY Change 126.9% 165.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.48M $13.07M
Total Long-Term Liabilities $88.07M $60.06M
Total Liabilities $168.5M $73.14M
YoY Change 284.69% 204.27%
SHAREHOLDERS EQUITY
Retained Earnings -$187.8M -$139.0M
YoY Change 68.54% 73.94%
Common Stock $177.6M $124.5M
YoY Change 45.02% 57.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.22M -$14.54M
YoY Change
Total Liabilities & Shareholders Equity $158.3M $58.59M
YoY Change 188.63% 151.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$9.712M -$27.62M
YoY Change -26.14% 93.01%
Depreciation, Depletion And Amortization $34.26K $22.62K
YoY Change 31.78% -33.9%
Cash From Operating Activities $17.49M -$5.882M
YoY Change -592.52% 11.18%
INVESTING ACTIVITIES
Capital Expenditures $35.17K -$2.670K
YoY Change 402.79%
Acquisitions
YoY Change
Other Investing Activities -$4.632M -$7.350M
YoY Change -82.86% -21.05%
Cash From Investing Activities -$4.668M -$7.347M
YoY Change -82.74% -21.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -779.2K 10.23M
YoY Change -102.08% 84.12%
NET CHANGE
Cash From Operating Activities 17.49M -5.882M
Cash From Investing Activities -4.668M -7.347M
Cash From Financing Activities -779.2K 10.23M
Net Change In Cash 12.05M -3.000M
YoY Change 75.59% -66.83%
FREE CASH FLOW
Cash From Operating Activities $17.49M -$5.882M
Capital Expenditures $35.17K -$2.670K
Free Cash Flow $17.46M -$5.880M
YoY Change -590.56% 11.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001502377
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35770
dei Entity Registrant Name
EntityRegistrantName
CONTANGO ORE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3431051
dei Entity Address Address Line1
EntityAddressAddressLine1
516 2nd Avenue, Suite 401
dei Entity Address City Or Town
EntityAddressCityOrTown
Fairbanks
dei Entity Address State Or Province
EntityAddressStateOrProvince
AK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
99701
dei City Area Code
CityAreaCode
907
dei Local Phone Number
LocalPhoneNumber
888-4273
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 per share
dei Trading Symbol
TradingSymbol
CTGO
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12228479
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36165442
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15504819
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
235364
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
232572
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1083910
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1112910
CY2024Q3 us-gaap Assets Current
AssetsCurrent
37484716
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16850301
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
67544376
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
28064405
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52485380
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13326347
CY2024Q3 ctgo Commitment Fee
CommitmentFee
76696
CY2023Q4 ctgo Commitment Fee
CommitmentFee
350575
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
740700
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
120847152
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41741327
CY2024Q3 us-gaap Assets
Assets
158331868
CY2023Q4 us-gaap Assets
Assets
58591628
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2378654
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
250739
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12227927
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2241087
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
30254431
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2679784
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
34900000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7900000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
718827
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
80479839
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13071610
CY2024Q3 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
1135611
CY2023Q4 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
1200000
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
255769
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
246227
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1100480
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1100480
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
44285191
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
20737997
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38962344
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36779859
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2330577
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
88069972
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
60064563
CY2024Q3 us-gaap Liabilities
Liabilities
168549811
CY2023Q4 us-gaap Liabilities
Liabilities
73136173
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12226238
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12223758
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9454233
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9451753
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
122261
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
94542
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177505358
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
124451067
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2480
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2480
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
48308
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
48308
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-187797254
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139041846
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-10217943
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14544545
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158331868
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58591628
CY2024Q3 ctgo Claim Rental Expense
ClaimRentalExpense
180276
CY2023Q3 ctgo Claim Rental Expense
ClaimRentalExpense
127006
ctgo Claim Rental Expense
ClaimRentalExpense
436510
ctgo Claim Rental Expense
ClaimRentalExpense
379909
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
2957498
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
1081927
us-gaap Exploration Expense
ExplorationExpense
3079930
us-gaap Exploration Expense
ExplorationExpense
2344307
CY2024Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
34253
CY2023Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
25997
us-gaap Depreciation Nonproduction
DepreciationNonproduction
88245
us-gaap Depreciation Nonproduction
DepreciationNonproduction
94070
CY2024Q3 us-gaap Accretion Expense
AccretionExpense
3221
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
3183
us-gaap Accretion Expense
AccretionExpense
9542
us-gaap Accretion Expense
AccretionExpense
9069
CY2024Q3 ctgo Impairment From Casualty Loss
ImpairmentFromCasualtyLoss
0
CY2023Q3 ctgo Impairment From Casualty Loss
ImpairmentFromCasualtyLoss
0
ctgo Impairment From Casualty Loss
ImpairmentFromCasualtyLoss
0
ctgo Impairment From Casualty Loss
ImpairmentFromCasualtyLoss
7111
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2611625
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2767477
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7272026
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7258440
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
5786873
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
4005590
us-gaap Costs And Expenses
CostsAndExpenses
10886253
us-gaap Costs And Expenses
CostsAndExpenses
10092906
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
28525857
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5609288
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27689971
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17419288
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
22738984
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9614878
us-gaap Operating Income Loss
OperatingIncomeLoss
16803718
us-gaap Operating Income Loss
OperatingIncomeLoss
-27512194
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
76313
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
39045
us-gaap Investment Income Interest
InvestmentIncomeInterest
98772
us-gaap Investment Income Interest
InvestmentIncomeInterest
52352
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3683150
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-847983
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8634514
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1911472
CY2024Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-28844179
CY2023Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-2725411
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-57023000
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-2725411
CY2024Q3 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
873984
CY2023Q3 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
873984
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-219930
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-219930
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
64389
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
64389
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
606499
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31732573
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3534349
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-64840299
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3978032
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8993589
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13149227
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48036581
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31490226
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
718827
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
718827
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-9712416
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-13149227
us-gaap Net Income Loss
NetIncomeLoss
-48755408
us-gaap Net Income Loss
NetIncomeLoss
-31490226
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.93
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11973992
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11973992
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8935863
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8935863
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10447870
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10447870
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8009699
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8009699
us-gaap Net Income Loss
NetIncomeLoss
-48755408
us-gaap Net Income Loss
NetIncomeLoss
-31490226
us-gaap Share Based Compensation
ShareBasedCompensation
1973164
us-gaap Share Based Compensation
ShareBasedCompensation
2072650
us-gaap Depreciation
Depreciation
88245
us-gaap Depreciation
Depreciation
94070
us-gaap Accretion Expense
AccretionExpense
9542
us-gaap Accretion Expense
AccretionExpense
9069
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7111
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27689971
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17419288
ctgo Cash Distribution Received
CashDistributionReceived
19500000
ctgo Cash Distribution Received
CashDistributionReceived
0
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-51121840
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2725411
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-219930
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0
us-gaap Paid In Kind Interest
PaidInKindInterest
300048
us-gaap Paid In Kind Interest
PaidInKindInterest
505535
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-606500
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2994669
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-39056
ctgo Non Cash Other Income From Reimbursement Of Silver Royalty
NonCashOtherIncomeFromReimbursementOfSilverRoyalty
64389
ctgo Non Cash Other Income From Reimbursement Of Silver Royalty
NonCashOtherIncomeFromReimbursementOfSilverRoyalty
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-370242
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21486
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9852343
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1596295
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
718827
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10639082
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7684867
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
31290000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
38840000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42344
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6995
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31914758
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38847714
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
60686
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6886000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
17647500
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
ctgo Proceeds From Issuance Of Common Stock And Warrant Net
ProceedsFromIssuanceOfCommonStockAndWarrantNet
15477398
ctgo Proceeds From Issuance Of Common Stock And Warrant Net
ProceedsFromIssuanceOfCommonStockAndWarrantNet
34144190
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1538307
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2342269
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41939091
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56274735
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20663415
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9742154
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15737391
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8996154
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36400806
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18738308
us-gaap Interest Paid Net
InterestPaidNet
4672934
us-gaap Interest Paid Net
InterestPaidNet
1079971
ctgo Commitment Fee Derecognized And Added To Debt Discount
CommitmentFeeDerecognizedAndAddedToDebtDiscount
679943
ctgo Commitment Fee Derecognized And Added To Debt Discount
CommitmentFeeDerecognizedAndAddedToDebtDiscount
0
us-gaap Stock Issued1
StockIssued1
35331402
us-gaap Stock Issued1
StockIssued1
0
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
557945
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
ctgo Accrued Transaction Costs For Acquisition
AccruedTransactionCostsForAcquisition
255120
ctgo Accrued Transaction Costs For Acquisition
AccruedTransactionCostsForAcquisition
0
ctgo Fair Value Of Investing Activities Assumed
FairValueOfInvestingActivitiesAssumed
36824410
ctgo Fair Value Of Investing Activities Assumed
FairValueOfInvestingActivitiesAssumed
0
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-37879472
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
660985
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1350275
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
68715
CY2024Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
35331402
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
99998
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-9712416
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-10217943
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4773438
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
739783
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30400000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2221392
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
66658
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
21190
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-13149227
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11041194
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14544545
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1973164
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14695999
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1365325
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
35331402
ctgo Stock Issued During Period Value Warrants Issuance
StockIssuedDuringPeriodValueWarrantsIssuance
2146722
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300048
us-gaap Net Income Loss
NetIncomeLoss
-48755408
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-10217943
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-777383
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2072650
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36477528
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2811001
ctgo Stock Issued During Period Shares Treasury Stock Reissued Value
StockIssuedDuringPeriodSharesTreasuryStockReissuedValue
39481
ctgo Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5858772
ctgo Stock Issued During Period Value Warrant Modification
StockIssuedDuringPeriodValueWarrantModification
-382769
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1848179
ctgo Stock Issued During Period Shares Treasury Stock Issued For Convertible Note Interest Payment
StockIssuedDuringPeriodSharesTreasuryStockIssuedForConvertibleNoteInterestPayment
238886
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
505535
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
60686
us-gaap Net Income Loss
NetIncomeLoss
-31490226
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11041194
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2. Basis of Presentation and Immaterial Correction of the Presentation of Income/(Loss) from Equity Investment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p id="led470819f20239231698094677203" style="text-indent:4.44%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), including instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete annual consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes included in the Company’s Form 10-KT for the six-month period ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">D</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ecember 31, 2023 and its Form 10-K for the fiscal year ended June 30, 2023. The results of operations for the </span><span id="led470819f20239231698093792607"></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.</span></p><p style="text-indent:4.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has reclassified the presentation of the “Income/(loss) from equity investment in Peak Gold, LLC” in its Statements of Operations for the nine months ended September 30, 2024. The “Income/(loss) from equity investment in Peak Gold, LLC” was previously presented in “Other Income/(Expense)” and is now presented within income from operations on the Statement of Operations. The change in presentation will have no impact on Net Income/(Loss) for all impacted periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<p style="text-indent:4.44%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Non-designated Hedges.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to gold movements and the Company has elected not to apply hedge accounting. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.</span></p>
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1083910
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1112910
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9712416
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11973992
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13149227
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8935863
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9712416
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11973992
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13149227
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8935863
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48755408
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10447870
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.67
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31490226
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8009699
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.93
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-48755408
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10447870
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.67
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-31490226
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8009699
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.93
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
866875
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
866875
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
501000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
501000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
437089
CY2024Q3 ctgo Sharebased Compensation Arrangement By Sharebased Payment Award Options And Warrants Outstanding Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndWarrantsOutstandingNumber
866875
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
333109
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244864
us-gaap Asset Impairment Charges
AssetImpairmentCharges
122171
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
122136
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52485380
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13326347
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y3M21D
CY2019Q1 ctgo Contingent Salary And Compensation Retention Agreement
ContingentSalaryAndCompensationRetentionAgreement
1000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0151
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0151
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 ctgo Deferred Tax Liability On Acquisition Of Exploration And Evaluation Assets
DeferredTaxLiabilityOnAcquisitionOfExplorationAndEvaluationAssets
2330577
ctgo Percentage Of Taxable Income To Nols
PercentageOfTaxableIncomeToNols
0.80
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
73862344
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
44679859
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
34900000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7900000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38962344
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36779859
CY2024Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-74539622
CY2024Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-74539622
CY2024Q3 ctgo Gain Losses On Metal Sales
GainLossesOnMetalSales
900000
ctgo Gain Losses On Metal Sales
GainLossesOnMetalSales
900000
CY2023Q3 ctgo Gain Losses On Metal Sales
GainLossesOnMetalSales
0
ctgo Gain Losses On Metal Sales
GainLossesOnMetalSales
0
CY2024Q3 us-gaap Marketing Expense
MarketingExpense
183181
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
57349
us-gaap Marketing Expense
MarketingExpense
434080
us-gaap Marketing Expense
MarketingExpense
238708
CY2024Q3 ctgo Office And Administrative Costs
OfficeAndAdministrativeCosts
232602
CY2023Q3 ctgo Office And Administrative Costs
OfficeAndAdministrativeCosts
68813
ctgo Office And Administrative Costs
OfficeAndAdministrativeCosts
347651
ctgo Office And Administrative Costs
OfficeAndAdministrativeCosts
215356
CY2024Q3 us-gaap Insurance Tax
InsuranceTax
352942
CY2023Q3 us-gaap Insurance Tax
InsuranceTax
259798
us-gaap Insurance Tax
InsuranceTax
962118
us-gaap Insurance Tax
InsuranceTax
750174
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
236372
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
457680
us-gaap Professional Fees
ProfessionalFees
941984
us-gaap Professional Fees
ProfessionalFees
1249259
CY2024Q3 ctgo Regulatory Fees
RegulatoryFees
161449
CY2023Q3 ctgo Regulatory Fees
RegulatoryFees
145006
ctgo Regulatory Fees
RegulatoryFees
345731
ctgo Regulatory Fees
RegulatoryFees
317598
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
500550
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
819077
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1497079
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1740765
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
660985
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
739784
us-gaap Share Based Compensation
ShareBasedCompensation
1973164
us-gaap Share Based Compensation
ShareBasedCompensation
2072650
CY2024Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
101968
CY2023Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
48720
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
288643
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
146430
CY2024Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
181576
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
171250
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
481576
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
527500
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2611625
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2767477
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7272026
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7258440
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-126724-index-headers.html Edgar Link pending
0000950170-24-126724-index.html Edgar Link pending
0000950170-24-126724.txt Edgar Link pending
0000950170-24-126724-xbrl.zip Edgar Link pending
ctgo-20240930.htm Edgar Link pending
ctgo-20240930.xsd Edgar Link pending
ctgo-ex10_1.htm Edgar Link pending
ctgo-ex10_2.htm Edgar Link pending
ctgo-ex31_1.htm Edgar Link pending
ctgo-ex31_2.htm Edgar Link pending
ctgo-ex32_1.htm Edgar Link pending
ctgo-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ctgo-20240930_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending